Artivion (AORT) Cash & Equivalents (2010 - 2026)

Artivion's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $55.8 million for Q1 2026.

• Quarterly Cash & Equivalents rose 47.94% year-over-year to $55.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.8 million (up 47.94% YoY) and the FY2025 annual result came in at $64.9 million, up 21.41% from the prior year.
• Cash & Equivalents was $55.8 million for Q1 2026 at Artivion, down from $64.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $73.4 million in Q3 2025 and bottomed at $10.0 million in Q2 2022.
• A 5-year average of $48.9 million and a median of $53.5 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 80.14% — and 2023, when it soared 386.53%.
• Artivion's Cash & Equivalents stood at $39.4 million in 2022, then surged by 49.78% to $58.9 million in 2023, then decreased by 9.29% to $53.5 million in 2024, then advanced by 21.41% to $64.9 million in 2025, then slipped by 14.09% to $55.8 million in 2026.
• Business Quant data shows AORT's Cash & Equivalents at $55.8 million in Q1 2026, $64.9 million in Q4 2025, and $73.4 million in Q3 2025.